(NBG6) NÜRNBERGER Beteiligungs-AG - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DE0008435967
NBG6: Life, Health, Liability, Property, Casualty
NÜRNBERGER Beteiligungs-AG is a German insurance and financial services company headquartered in Nuremberg. Established in 1884, it has a long-standing presence in the European insurance market. The company offers a diverse range of insurance products, including life, health, liability, and property insurance. Its life insurance portfolio includes term life, whole life, and pension plans, while its health insurance offerings cover private health, dental, and supplementary hospital insurance. The company also provides liability insurance for individuals and professionals, as well as property insurance for homes, vehicles, and other assets.
In addition to its insurance products, NÜRNBERGER Beteiligungs-AG provides financial services such as asset management, financing, and institutional consulting. The company has a strong focus on risk management and customer-centric solutions, catering to both individual and corporate clients. Its product range is designed to address a wide array of risks, from personal health and liability to professional and property-related risks.
As of the latest data, the companys stock (Ticker: NBG6) trades on the XETRA exchange with a market capitalization of 487.30M EUR. The stock has shown moderate volatility, with an Average True Range (ATR) of 1.63 and an average 20-day volume of 1375 shares. The price-to-book (P/B) ratio stands at 0.55, indicating a potential undervaluation relative to its book value. The price-to-sales (P/S) ratio of 0.10 suggests a low valuation compared to its revenue generation.
The companys return on equity (RoE) is reported at 2.15, reflecting moderate profitability. The lack of forward P/E data suggests uncertainty or limited visibility into future earnings. The stocks recent price of 42.30 EUR is below its 20-day (43.32) and 50-day (45.36) moving averages, indicating short-term downward momentum. However, it remains above its 200-day moving average of 51.43, which could signal support at higher levels.
Additional Sources for NBG6 Stock
NBG6 Stock Overview
Market Cap in USD | 554m |
Sector | Financial Services |
Industry | Insurance - Diversified |
GiC Sub-Industry | Multi-line Insurance |
IPO / Inception |
NBG6 Stock Ratings
Growth Rating | -49.5 |
Fundamental | -12.6 |
Dividend Rating | 57.6 |
Rel. Strength | -43.5 |
Analysts | - |
Fair Price Momentum | 39.26 EUR |
Fair Price DCF | 222.32 EUR |
NBG6 Dividends
Dividend Yield 12m | 7.66% |
Yield on Cost 5y | 6.48% |
Annual Growth 5y | 1.18% |
Payout Consistency | 97.8% |
NBG6 Growth Ratios
Growth Correlation 3m | -83.5% |
Growth Correlation 12m | -97.7% |
Growth Correlation 5y | -31.5% |
CAGR 5y | -7.04% |
CAGR/Max DD 5y | -0.15 |
Sharpe Ratio 12m | -0.13 |
Alpha | -37.35 |
Beta | 0.139 |
Volatility | 50.61% |
Current Volume | 2.5k |
Average Volume 20d | 1.4k |
As of April 19, 2025, the stock is trading at EUR 42.00 with a total of 2,545 shares traded.
Over the past week, the price has changed by +4.74%, over one month by -5.41%, over three months by -11.02% and over the past year by -32.80%.
Neither. Based on ValueRay Fundamental Analyses, NÜRNBERGER Beteiligungs-AG is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -12.57 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of NBG6 as of April 2025 is 39.26. This means that NBG6 is currently overvalued and has a potential downside of -6.52%.
NÜRNBERGER Beteiligungs-AG has no consensus analysts rating.
According to ValueRays Forecast Model, NBG6 NÜRNBERGER Beteiligungs-AG will be worth about 42.4 in April 2026. The stock is currently trading at 42.00. This means that the stock has a potential upside of +0.95%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 60 | 42.9% |
Analysts Target Price | - | - |
ValueRay Target Price | 42.4 | 1% |